With Fewer PSA Tests, Rate of Advanced Prostate Cancers Rose
WEDNESDAY, March 16, 2022 (HealthDay News) — Ever since routine prostate-specific antigen (PSA) screening tests have no longer been recommended, there has been a troubling rise in advanced prostate cancer cases in the United States, new research has found. The tests measure the amount of PSA in the blood, and elevated levels can signal the … Read more